The team discovered a unique population of immune cells that is important to the successful treatment of relapsed acute myeloid leukemia (AML). This investigation was done in partnership with the Dana Farber Cancer Institute (DFCI). Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/immune-cells-found-to-boost-cancer-treatment-in-acute-myeloid-leukemia-study/117571157